|Articles|June 2, 2003
- Pharmaceutical Technology-06-02-2003
- Volume 27
- Issue 6
Formulation Development of a Nucleotide Phosphoramidate
Author(s)Manoj Maniar, PhD
A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
Advertisement
Articles in this issue
about 23 years ago
June 2003about 23 years ago
From Genome Exploration to Drug Developmentabout 23 years ago
Are you ready for Gen3about 23 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's Next AI Problem Is Authority
2
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
3
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5